Philip Mitchell has provided health regulatory counsel to a range of industry clients, including hospital systems, provider practice groups, management services organizations, clinical laboratories, managed care organizations and health insurers, pharmaceutical and biologic manufacturers, and specialty pharmacies, other proprietary and nonprofit healthcare enterprises, and investment firms.

Download full bio 

Experience

  • Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III 

  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion 

  • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 

  • View all

Education

  • University of Virginia School of Law
    JD, 1986

  • Princeton University, Woodrow Wilson School
    MPA, 1987

  • University of Pennsylvania, The Wharton School
    BS, 1982

  • University of Pennsylvania, The College of Arts and Sciences
    BA, 1982


Admissions & Credentials

New Jersey

New York

Pennsylvania

Memberships

  • American Bar Association

  • American Health Lawyers Association